Log In
BCIQ
Print this Print this
 

MIMP

  Manage Alerts
Collapse Summary General Information
Company IRX Therapeutics Inc.
DescriptionMethyl 5 inosine monophosphate
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationInfluenza virus
Indication DetailsPrevent influenza in at risk population
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today